Eric Liu, Pharm.D
About Eric Liu, Pharm.D
Eric Liu, Pharm.D, is an Investment Banking Associate at Piper Sandler, where he provides advisory services for life sciences clients in healthcare. He holds a Doctor of Pharmacy degree from Rutgers University and has extensive experience in pharmacy management and clinical practice.
Work at Piper Sandler
Eric Liu currently serves as an Investment Banking Associate at Piper Sandler, a position he has held since 2023. In this role, he provides advisory services specifically tailored for life sciences clients in the healthcare sector. Prior to this position, he gained experience as an Investment Banking Summer Associate at Piper Sandler in 2022, where he worked for three months in New York City.
Education and Expertise
Eric Liu holds a Doctor of Pharmacy (Pharm.D) degree from the Ernest Mario School of Pharmacy at Rutgers University, which he completed from 2010 to 2016. He furthered his education by obtaining a Master of Business Administration (MBA) from NYU Stern School of Business, where he studied from 2021 to 2023. His educational background equips him with a strong foundation in both pharmacy and business, enhancing his capabilities in investment banking.
Background in Pharmacy
Eric Liu has extensive experience in the pharmacy field. He worked at Walgreens in various roles, including Pharmacy Manager from 2018 to 2019, Health Advisor Pharmacist for five months in 2021, and Staff Pharmacist from 2016 to 2018. Additionally, he served as a Pharmacy Intern at Walgreens from 2013 to 2016. His experience also includes a position as Director of Pharmacy Operations at Tarrytown Expocare Pharmacy in 2019.
Internship Experience
Eric Liu gained valuable experience through internships in the healthcare sector. He worked as a Corporate Business Development and Leadership Intern at CVS Health in 2015 for four months. This role provided him with insights into corporate operations within the healthcare industry, complementing his pharmacy background and preparing him for his transition into investment banking.